Clinical Trials Browser

Phase 4 × Neurocognitive Disorders × Dexmedetomidine × Clear all

NCT02810899 2016-09-29

Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy

Phase 4 Completed

Brain Neoplasms, Neurocognitive Disorders